N-(3-(2-(5-methyl-1H-benzo[d]imidazol-2-yl)ethyl)phenyl)-1-(pyrrolidin-1-ylsulfonyl)piperidine-3-carboxamide

ID: ALA4798059

PubChem CID: 20933755

Max Phase: Preclinical

Molecular Formula: C26H33N5O3S

Molecular Weight: 495.65

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc2[nH]c(CCc3cccc(NC(=O)C4CCCN(S(=O)(=O)N5CCCC5)C4)c3)nc2c1

Standard InChI:  InChI=1S/C26H33N5O3S/c1-19-9-11-23-24(16-19)29-25(28-23)12-10-20-6-4-8-22(17-20)27-26(32)21-7-5-15-31(18-21)35(33,34)30-13-2-3-14-30/h4,6,8-9,11,16-17,21H,2-3,5,7,10,12-15,18H2,1H3,(H,27,32)(H,28,29)

Standard InChI Key:  NRMUDLHKZHSPPI-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 39  0  0  0  0  0  0  0  0999 V2000
   16.7779   -8.9911    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.7821   -9.8160    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   17.4944   -9.3999    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.0856  -10.1825    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.0844  -11.0098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7992  -11.4227    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7973   -9.7698    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5127  -10.1789    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.5175  -11.0053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.3050  -11.2561    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.7868  -10.5846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.2971   -9.9191    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3696  -11.4218    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.6118  -10.5798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0200   -9.8629    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8450   -9.8581    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2596  -10.5720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0837  -10.5675    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4927   -9.8501    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.0717   -9.1358    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.2489   -9.1438    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4774   -8.4175    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3022   -8.4097    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7081   -7.6914    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7215   -9.1203    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3119   -9.8374    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7276  -10.5458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5529  -10.5422    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.9608   -9.8242    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.5434   -9.1096    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2025  -10.5311    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.8759  -11.2841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.4923  -11.8324    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.2042  -11.4156    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0277  -10.6098    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  2  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12  8  1  0
  5 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 16  1  0
 20 22  1  0
 22 23  1  0
 23 24  2  0
 23 25  1  0
 25 26  1  0
 25 30  1  0
 26 27  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 29  2  1  0
  2 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  1  0
 35 31  1  0
M  END

Associated Targets(Human)

BXPC-3 (2997 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CAPAN-1 (772 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 495.65Molecular Weight (Monoisotopic): 495.2304AlogP: 3.65#Rotatable Bonds: 7
Polar Surface Area: 98.40Molecular Species: NEUTRALHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.80CX Basic pKa: 6.61CX LogP: 3.17CX LogD: 3.11
Aromatic Rings: 3Heavy Atoms: 35QED Weighted: 0.52Np Likeness Score: -1.83

References

1. Myers SH,Ortega JA,Cavalli A.  (2020)  Synthetic Lethality through the Lens of Medicinal Chemistry.,  63  (23.0): [PMID:33135887] [10.1021/acs.jmedchem.0c00766]

Source